Back

State of the Art - Novel therapies for acute myocardial infarction

3 September 2019 (11:20 - 11:34)
Organised by:
Congress Presentation Part of: Emerging treatments in acute coronary syndromes Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Gerd Heusch

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

3 More presentations in this session

Presentation thumbnail
Inhibition of platelet aggregation after subcutaneous administration of a single-dose of selatogrel, a novel P2Y12 antagonist, in acute myocardial infarction: a randomised open-label phase 2 study
Professor P. Sinnaeve (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study
Doctor A. Abbate (Charlottesville, US)
Abstract Slides Video
Presentation thumbnail
KAND567, the first selective small molecule CX3CR1 antagonist in clinical development, mediates anti-inflammatory cardioprotective effects in rodent models of atherosclerosis and myocardial infarction
Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Emerging treatments in acute coronary syndromes

The Event

Event poster

ESC Congress 2019

3 September 2019 11:20 CET
You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Intravenous administration of IV-STATIN CARDIOSHIELD during myocardial infarction renders higher cardioprotection than oral atorvastatin given shortly after reperfusion: a translational CMR study
1 September 2019
thumbnail
Congress Presentation
Pro-efferocytic heart-homing polymeric nanoparticles alleviate acute myocardial infraction injury
29 August 2025
thumbnail
Webinar
Prevention of heart failure post-acute myocardial infarction
12 January 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources